Literature DB >> 27739441

Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.

Yue Xue1, Alessandro Vanoli2, Serdar Balci1, Michelle M Reid1, Burcu Saka1, Pelin Bagci1, Bahar Memis1, Hyejeong Choi3, Nobuyike Ohike4, Takuma Tajiri5, Takashi Muraki1, Brian Quigley1, Bassel F El-Rayes6, Walid Shaib6, David Kooby7, Juan Sarmiento7, Shishir K Maithel7, Jessica H Knight8, Michael Goodman8, Alyssa M Krasinskas1, Volkan Adsay1.   

Abstract

Literature on non-ampullary-duodenal carcinomas is limited. We analyzed 47 resected non-ampullary-duodenal carcinomas. Histologically, 78% were tubular-type adenocarcinomas mostly gastro-pancreatobiliary type and only 19% pure intestinal. Immunohistochemistry (n=38) revealed commonness of 'gastro-pancreatobiliary markers' (CK7 55, MUC1 50, MUC5AC 50, and MUC6 34%), whereas 'intestinal markers' were relatively less common (MUC2 36, CK20 42, and CDX2 44%). Squamous and mucinous differentiation were rare (in five each); previously, unrecognized adenocarcinoma patterns were noted (three microcystic/vacuolated, two cribriform, one of comedo-like, oncocytic papillary, and goblet-cell-carcinoid-like). An adenoma component common in ampullary-duodenal cancers was noted in only about a third. Most had plaque-like or ulcerating growth. Mismatch repair protein alterations were detected in 13% (all with plaque-like growth and pushing-border infiltration). When compared with ampullary (n=355) and pancreatic ductal (n=227) carcinomas, non-ampullary-duodenal carcinomas had intermediary pathologic features with mean invasive size of 2.9 cm (vs 1.9, and 3.3) and 59% nodal metastasis (vs 45, and 77%). Its survival (3-, 5-year rates of 57 and 57%) was similar to that of ampullary-duodenal carcinomas (59 and 52%; P=0.78), but was significantly better than the ampullary ductal (41 and 29%, P<0.001) and pancreatic (28 and 18%, P<0.001) carcinomas. In conclusion, non-ampullary-duodenal carcinomas are more histologically heterogeneous than previously appreciated. Their morphologic versatility (commonly showing gastro-pancreatobiliary lineage and hitherto unrecognized patterns), frequent plaque-like growth minus an adenoma component, and frequent expression of gastro-pancreatobiliary markers suggest that many non-ampullary-duodenal carcinomas may arise from Brunner glands or gastric metaplasia or heterotopic pancreatobiliary epithelium. The clinical behavior of non-ampullary-duodenal carcinoma is closer to that of ampullary-duodenal subset of ampullary carcinomas, but is significantly better than that of ampullary ductal and pancreatic cancers. The frequency of mismatch repair protein alterations suggest that routine testing should be considered, especially in the non-ampullary-duodenal carcinomas with plaque-like growth and pushing-border infiltration.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27739441     DOI: 10.1038/modpathol.2016.174

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  16 in total

1.  Extra-ampullary duodenal adenocarcinoma.

Authors:  Tetsuo Ushiku; Thomas Arnason; Masashi Fukayama; Gregory Y Lauwers
Journal:  Am J Surg Pathol       Date:  2014-11       Impact factor: 6.394

2.  Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.

Authors:  Michelle D Reid; Serdar Balci; Nobuyuki Ohike; Yue Xue; Grace E Kim; Takuma Tajiri; Bahar Memis; Ipek Coban; Anil Dolgun; Alyssa M Krasinskas; Olca Basturk; David A Kooby; Juan M Sarmiento; Shishir K Maithel; Bassel F El-Rayes; Volkan Adsay
Journal:  Mod Pathol       Date:  2016-09-02       Impact factor: 7.842

3.  Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.

Authors:  Sun-Young Jun; Dae Woon Eom; Hosub Park; Young Kyung Bae; Kee-Taek Jang; Eunsil Yu; Seung-Mo Hong
Journal:  Mod Pathol       Date:  2014-03-07       Impact factor: 7.842

4.  Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.

Authors:  Nobuyuki Ohike; Grace E Kim; Takuma Tajiri; Alyssa Krasinskas; Olca Basturk; Ipek Coban; Sudeshna Bandyopadhyay; Toshio Morohoshi; Michael Goodman; David A Kooby; Juan M Sarmiento; N Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2010-12       Impact factor: 6.394

5.  Vacuolated cell pattern of pancreatobiliary adenocarcinoma: a clinicopathological analysis of 24 cases of a poorly recognized distinctive morphologic variant important in the differential diagnosis.

Authors:  Nevra Dursun; Jining Feng; Olca Basturk; Sudeshna Bandyopadhyay; Jeanette D Cheng; Volkan N Adsay
Journal:  Virchows Arch       Date:  2010-10-08       Impact factor: 4.064

6.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  C J Yeo; T A Sohn; J L Cameron; R H Hruban; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

7.  Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival.

Authors:  Aaron Struck; Thomas Howard; Elena G Chiorean; Jeffrey M Clarke; Robert Riffenburgh; Higinia R Cardenes
Journal:  J Surg Oncol       Date:  2009-08-01       Impact factor: 3.454

8.  Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?

Authors:  Arne Westgaard; Ewa Pomianowska; Ole Petter F Clausen; Ivar P Gladhaug
Journal:  Ann Surg Oncol       Date:  2012-09-07       Impact factor: 5.344

9.  Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.

Authors:  Maryam Zenali; Michael J Overman; Asif Rashid; Russell B Broaddus; Hua Wang; Matthew H Katz; Jason B Fleming; James L Abbruzzese; Huamin Wang
Journal:  Hum Pathol       Date:  2013-10-15       Impact factor: 3.466

10.  Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine.

Authors:  M J Overman; J Pozadzides; S Kopetz; S Wen; J L Abbruzzese; R A Wolff; H Wang
Journal:  Br J Cancer       Date:  2009-11-24       Impact factor: 7.640

View more
  10 in total

1.  Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns.

Authors:  Alessandro Vanoli; Antonio Di Sabatino; Michele Martino; Catherine Klersy; Federica Grillo; Claudia Mescoli; Gabriella Nesi; Umberto Volta; Daniele Fornino; Ombretta Luinetti; Paolo Fociani; Vincenzo Villanacci; Francesco P D'Armiento; Renato Cannizzaro; Giovanni Latella; Carolina Ciacci; Livia Biancone; Marco Paulli; Fausto Sessa; Massimo Rugge; Roberto Fiocca; Gino R Corazza; Enrico Solcia
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

2.  APC mutations are common in adenomas but infrequent in adenocarcinomas of the non-ampullary duodenum.

Authors:  Kenichi Ishizu; Taiki Hashimoto; Tomoaki Naka; Yasushi Yatabe; Motohiro Kojima; Takeshi Kuwata; Satoru Nonaka; Ichiro Oda; Minoru Esaki; Masashi Kudo; Naoto Gotohda; Teruhiko Yoshida; Takaki Yoshikawa; Shigeki Sekine
Journal:  J Gastroenterol       Date:  2021-09-12       Impact factor: 7.527

3.  Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study.

Authors:  Giovanni Arpa; Matteo Fassan; Camilla Guerini; Erica Quaquarini; Federica Grillo; Valentina Angerilli; Vincenza Guzzardo; Sara Lonardi; Francesca Bergamo; Marco Vincenzo Lenti; Paolo Pedrazzoli; Marco Paulli; Antonio Di Sabatino; Alessandro Vanoli
Journal:  Virchows Arch       Date:  2022-08-04       Impact factor: 4.535

Review 4.  Small Bowel Epithelial Precursor Lesions: A Focus on Molecular Alterations.

Authors:  Alessandro Vanoli; Federica Grillo; Daniela Furlan; Giovanni Arpa; Oneda Grami; Camilla Guerini; Roberta Riboni; Luca Mastracci; Antonio Di Sabatino
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

5.  Surgical treatment of duodenal adenocarcinoma: ampullary vs. non-ampullary, short- and long-term outcomes.

Authors:  Jana Tesarikova; Pavel Skalicky; Daniela Kurfurstova; Hana Svebisova; Ondrej Urban; Premysl Falt; Jana Zapletalova; Dusan Klos; Martin Lovecek
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-05-11       Impact factor: 1.648

6.  Mixed Adenocarcinoma and Squamous Cell Carcinoma of Duodenum: A Case Report and Review of the Literature.

Authors:  Muhammad Bader Hammami; Anuj Chhaparia; Jinhua Piao; Yihua Zhou; Christine Hachem; Jinping Lai
Journal:  Case Rep Gastroenterol       Date:  2017-07-04

7.  Clinicopathological characteristics of duodenal epithelial neoplasms: Focus on tumors with a gastric mucin phenotype (pyloric gland-type tumors).

Authors:  Takehiro Mitsuishi; Shigeharu Hamatani; Shinichi Hirooka; Nei Fukasawa; Daisuke Aizawa; Yuko Hara; Akira Dobashi; Kenichi Goda; Takahiro Fukuda; Masayuki Saruta; Mitsuyoshi Urashima; Masahiro Ikegami
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

Review 8.  How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies.

Authors:  Richard Gallon; Peter Gawthorpe; Rachel L Phelps; Christine Hayes; Gillian M Borthwick; Mauro Santibanez-Koref; Michael S Jackson; John Burn
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

9.  Prognostic Factors and Clinical Characteristics of Duodenal Adenocarcinoma With Survival: A Retrospective Study.

Authors:  Huapeng Sun; Yi Liu; Long Lv; Jingwen Li; Xiaofeng Liao; Wei Gong
Journal:  Front Oncol       Date:  2021-12-15       Impact factor: 6.244

10.  Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas.

Authors:  Alessandro Vanoli; Federica Grillo; Camilla Guerini; Giuseppe Neri; Giovanni Arpa; Catherine Klersy; Gabriella Nesi; Paolo Giuffrida; Gianluca Sampietro; Sandro Ardizzone; Paolo Fociani; Roberto Fiocca; Giovanni Latella; Fausto Sessa; Antonietta D'Errico; Deborah Malvi; Claudia Mescoli; Massimo Rugge; Stefano Ferrero; Gilberto Poggioli; Fernando Rizzello; Maria C Macciomei; Donatella Santini; Umberto Volta; Roberto De Giorgio; Giacomo Caio; Antonio Calabrò; Carolina Ciacci; Maria D'Armiento; Aroldo Rizzo; Gaspare Solina; Michele Martino; Francesco Tonelli; Vincenzo Villanacci; Renato Cannizzaro; Vincenzo Canzonieri; Ada Maria Florena; Livia Biancone; Giovanni Monteleone; Roberto Caronna; Antonio Ciardi; Luca Elli; Flavio Caprioli; Maurizio Vecchi; Renata D'Incà; Fabiana Zingone; Anna D'Odorico; Marco Vincenzo Lenti; Barbara Oreggia; Luca Reggiani Bonetti; Antonino Giulio Giannone; Augusto Orlandi; Valeria Barresi; Rachele Ciccocioppo; Giuseppe Amodeo; Elena Biletta; Ombretta Luinetti; Paolo Pedrazzoli; Andrea Pietrabissa; Gino Roberto Corazza; Enrico Solcia; Marco Paulli; Antonio Di Sabatino
Journal:  Ann Surg Oncol       Date:  2020-08-05       Impact factor: 5.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.